EUVIMEDEUVIMED entdecken
Open Access

Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures

Fumio Fukuda, Naoaki Kurinomaru, Akihiko Hijioka

Biologics in Therapy · 2014

DOI: 10.1007/s13554-014-0013-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biologics in Therapy, 2014. Verfasst von Fumio Fukuda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kitakyushu General Hospital, 5-10-10 Kokura-Minami, Kitakyushu, 800-0295, Japan. f-fukuda@kitakyu-hp.or.jp. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The occurrence of atypical femur fractures (AFFs) in patients on prolonged bisphosphonate treatment has been gaining medical attention, but the use of pharmacotherapy for these fractures has not been explored in detail. The authors describe a case of AFFs successfully treated with once-weekly administration of 56.5 μg teriparatide (TPTD). CASE PRESENTATION: The patient was a 74-year-old female patient who had been taking alendronate for approximately 6 years and who suffered with a fall while walking. X-rays revealed a subtrochanteric right femur fracture. The contralateral femur showed cortical thickening and a transverse radiolucent fracture line. Based on these specific features, the patient was diagnosed with AFF. The patient underwent osteosynthesis with intramedullary nailing for the right fracture. Alendronate treatment was discontinued. Low-intensity pulsed ultrasonography therapy did not affect the healing of the fracture with delayed union, even after 3 months of application. Prophylactic osteosynthesis was performed for the subtrochanteric left femur. Bone tissue collected from the left fracture site during surgery showed severe suppression of bone turnover. Union of bilateral femurs was achieved after 3 months of a once-weekly administration of TPTD. CONCLUSION: Once-weekly TPTD treatment is shown to be beneficial for improving the healing of AFFs showing delayed union.

Schlagwörter

Stichwörter der Autor:innen

Atypical femoral fracturesBisphosphonatesDelayed unionTeriparatide

Autor:innen und Institutionen

  • Kitakyushu General Hospital, 5-10-10 Kokura-Minami, Kitakyushu, 800-0295, Japan. f-fukuda@kitakyu-hp.or.jp.
  • Kitakyushu General Hospital, 5-10-10 Kokura-Minami, Kitakyushu, 800-0295, Japan.

Zitieren

APA

Fukuda, F., Kurinomaru, N., & Hijioka, A. (2014). Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures. Biologics in Therapy. https://doi.org/10.1007/s13554-014-0013-5

Vancouver

Fukuda F, Kurinomaru N, Hijioka A. Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures. Biologics in Therapy. 2014. doi:10.1007/s13554-014-0013-5

BibTeX
@article{Fukuda2014,
  author = {Fukuda, Fumio and Kurinomaru, Naoaki and Hijioka, Akihiko},
  title = {Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures},
  journal = {Biologics in Therapy},
  year = {2014},
  doi = {10.1007/s13554-014-0013-5}
}
Kostenlos starten →